Study of Dasatinib in Combination With Everolimus for Children and Young Adults With Gliomas Harboring Platelet-Derived Growth Factor Receptor (PDGFR) Alterations
Clinical trial NCT03352427 · TERMINATED
Trial details
- NCT number
- NCT03352427
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-06
- Primary completion
- 2019-04-17
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.